Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth
20-Feb-2020
Europe
Market Outlook
MEE1-01-00-00-00
HC03266-EU-MO_24121
Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national healthcare policies and regulatory reforms that must re-invigorate future strategies. Social Determinants of Health (SDOH) will emerge as a big theme across progressive health systems as they seek to proactively engage patients and improve health outcomes that would help healthcare organizations meet quality standards.
This decade will bring significant changes and disruptions when it comes to digital-service-enabled health. Health and care delivery, as well as prevention in the 2020s, will become more consumer-centric, with AI-powered tools and virtual interactions between patients and care providers becoming the new normal in many situations. Data-driven interoperability and personalized diagnostics will accelerate the delivery of predictive-analysis-driven precision care. This will pave the way for better and efficient decision making for the patient and the provider and further drive partnerships between big tech companies that design care delivery models and healthcare organizations.
This follows the new vision for healthcare for 2020 and beyond, focusing not only on access, quality, and affordability but also on predictive, preventive, and outcome-based care models that promote social and financial inclusion. In 2020, consumer-driven models of healthcare will gain more market traction, as they stand to better bridge the gap of what consumers want and what healthcare can deliver.
Central and Eastern Europe is highly fragmented and is emerging as quite an attraction to healthcare investors. Screening services are facilitating better diagnosis of chronic conditions. The rise in disposable income and in healthcare spending is because of the presence of a rapidly aging population and their demand for better healthcare. Economic factors are also at play, with rising wages and disposable incomes freeing up personal money for healthcare-related spending. With the recent rise in minimum wages in Hungary and other recent reforms in various parts of Central and Eastern Europe, the economy in CEE and a parallel drop in unemployment rates are ideal for market participants.
Market Scope
Geographic Segmentation
Key Questions This Study Will Answer
Top Predictions for the EU Healthcare Industry, 2020
EU Healthcare Industry Forecast by Segment
EU Regional Performance Matrix
Revenue by Region
Prediction#1: By 2020, Orphan Drug R&D Pipeline will Surpass Non-orphan Drug to Account for 55% of the Total Pipeline Value
Prediction#2: Europe will Expand Biomanufacturing Capacity by ~15% to Reach a Market Share of 35% by 2020
Prediction#3: 2020 will be an Inflexion Point for Artificial Intelligence in Europe
Prediction#4: Hospital Cost Saving is Set to Increase by 25%–35% by 2020 as 15%–20% of ORs become Integrated
Prediction#5: POCT Market for Infectious Diseases will Breach the One-billion-dollar Mark in 2020
Prediction#6: Europe will Lead the Global IVF Market in 2020 and Account for 40% of Market Share
Prediction#7: The Demand for Precision Care Procedures will Fuel RASD to Reach $430 million by 2020 and Cut Complication Rates by 10%–15%
Prediction#8: Next-gen Imaging Equipment is set to Yield Annual Operational Savings of 10%–12%
Prediction#9: Medical-grade remote patient monitoring will witness a 15% growth
Prediction#10: Up to 20 New Enterprise-customer Partnerships will Redefine New Business Models
Top Pharmaceuticals and Biotechnology Growth Opportunities
Top Medical Technologies Growth Opportunities
Top Medical Imaging Equipment Growth Opportunities
Top In-Vitro Diagnostics Growth Opportunities
Top Healthcare IT Growth Opportunities
Companies to Watch Out For
Companies to Watch Out for (continued)
Healthcare IT
Medical Technologies
Medical Imaging Equipment
Pharmaceutical & Biotechnology
In-Vitro Diagnostics
UK and Europe’s Interdependencies that Support the Care Continuum
Select Indicators for Health System Assessment
Potential Disruption Across the UK Healthcare Sector
Critical Success Factors
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Outlook |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Bejoy Daniel |
| Industries | Healthcare |
| WIP Number | MEE1-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9575-B1,9600-B1,9612-B1,9570-B1,9571-B1,9573-B1,9A48-B1,9A4B-B1,9611-B1,9614-B1,9627-B1 |
EU Healthcare Predictions and Outlook, 2020
$4,950.00
Special Price $3,712.50 save 25 %